The prevalence of asymptomatic methicillin-resistant Staphylococcus aureus in school-age children

Yıl 2011, Cilt: 16 Sayı: 1, 18 - 21, 18.01.2013

Scott E. Woods Elizabeth Beiter Betsy Drake Amy Engel

Öz

Abstract. To investigate the prevalence of asymptomatic methicillin-resistant Staphylococcus aureus (MRSA) in school-age children, we conducted a cross-sectional study. We investigated the prevalence of asymptomatic MRSA in children at a single, private school serving a low-income population in 2009.  The school possesses Kindergarten through 8^th grade classes. We excluded all children currently on antibiotics effective against MRSA and all children treated for a skin infection in the previous month.  We sampled a single surface culture from both anterior nares.   Each swab was then tested for MRSA utilizing a polymerase chain reaction test. We collected the following data on each child: age, grade, gender, recent abscess, current antibiotics, family member with a recent abscess, heath care worker living with student, and participation in sports. Our study included 87 school-age children (57% of the total population). The participants had a mean age of 9.5 years, 50.6% were female, 4.6% reported an abscess in the last year, 9.2% had a family member with an abscess in the last year, 26.4% had a healthcare worker at home, and 64.4% participated in organized sports.  Six (6.9%) of the 87 children tested positive for MRSA.  There was no significant difference between MRSA positive students and MRSA negative students for age, grade, gender, abscess in last year, family member with an abscess, healthcare worker in the family and sports participation. The prevalence of MRSA in asymptomatic school-age children was seven percent.  Compared to other point prevalence studies, the prevalence of MRSA colonization appears to be rising.

Key words: Children, MRSA, carrier 

Anahtar Kelimeler

Children, MRSA, carrier

Kaynakça

• 1. Nakamura MM, Rohling KL, Shashaty M, et al. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002; 21: 917- 922.
• 2. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin - resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39: 776- 782.
• 3. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197: 1226-1234.
• 4. Purcell K, Fergie J. Epidemic of communityacquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med 2005; 159: 980-985.
• 5. www. melissadata. Com / lookups / TaxZip. Last visited on 12/22/10.
• 6. www.city-data.com/neighborhood/West-Price-HillCincinnati-OH.html Last visited 12/22/10.
• 7. Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24: 617-621.
• 8. Malik S, Vranken P, Silio M, Ratard R, Van Dyke R. Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization outside the healthcare environment. Epidemiol Infect 2009; 137: 1237-1241.
• 9. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346: 1871- 1877.
• 10. Wertheim HF, Vos MC, Ott A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364: 703-705.
• 11. Konvalinka A, Errett L, Fong IW. Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 2006; 64: 162-168.
• 12. Hansen D, Patzke PI, Werfel U, et al. Success of MRSA eradication in hospital routine: depends on compliance. Infection 2007; 35: 260-264.
• 13. Robicsek A, Beaumont JL, Thomson RB Jr, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009; 30: 623-632.